Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000531274 | SCV000637687 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2021-12-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002060314 | SCV002497925 | likely benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | CDH1: BP4 |
Myriad Genetics, |
RCV000531274 | SCV005407122 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-09-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV003960305 | SCV004768325 | likely benign | CDH1-related disorder | 2023-06-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |